BioInvent International AB (BINV) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

BioInvent International AB (BINV) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr66.78 Million) in capital expenditures (Skr1.38 Million). Check BioInvent International AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

Skr66.78 Million
SEK

Capital Expenditures

Skr1.38 Million
SEK

Data as of

Jun 2025
Most recent filing

BioInvent International AB Capital Reinvestment Ratio (2007–2008)

This chart tracks BioInvent International AB's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see BioInvent International AB cash conversion from operations.

Annual Capital Reinvestment Ratio for BioInvent International AB (2007–2008)

Year-by-year Capital Reinvestment Ratio for BioInvent International AB from 2007 to 2008. See how much free cash does BioInvent International AB generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2008 0.31x Skr43.73 Million Skr13.64 Million ▲ +0.8%
2007 0.31x Skr12.63 Million Skr3.91 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow